Guideline-Directed Medical Therapy is named as a drug or biological intervention in 3 clinical trials in our China trial register, 1 of which is recruiting. Lead sponsors include Nanjing First Hospital, Nanjing Medical University (2) and The First Affiliated Hospital with Nanjing Medical University (1). Registered phases: Not applicable and Phase 4. Conditions studied include Coronary Artery Disease (CAD); Heart Failure With Reduced Ejection Fraction; Coronary Artery Disease.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07349875 | Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial (ClinicalTrials.gov ↗) Coronary Artery Disease (CAD) |
Phase 4 | Recruiting |
| NCT07349979 | PCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF (ClinicalTrials.gov ↗) Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease, Stable GDMT |
Not applicable | Not yet open |
| NCT05572957 | LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB (ClinicalTrials.gov ↗) Non-ischemic Cardiomyopathy, Heart Failure, Left Bundle-Branch Block |
Not applicable | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Coronary Artery Disease (CAD) | 1 |
| Heart Failure With Reduced Ejection Fraction | 1 |
| Coronary Artery Disease | 1 |
| Stable GDMT | 1 |
| Non-ischemic Cardiomyopathy | 1 |
| Heart Failure | 1 |
| Left Bundle-Branch Block | 1 |
| Lead sponsor | Trials |
|---|---|
| Nanjing First Hospital, Nanjing Medical University | 2 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
| Register | Guideline-Directed Medical Therapy trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Guideline-Directed Medical Therapy works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Guideline-Directed Medical Therapy (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.